Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic modelsVijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports|August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarinQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
Basic & Clinical Pharmacology & Toxicology|July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic modelDaniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse SettingsStephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
The International Journal of Pharmacy Practice|April 13, 2022
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic reviewKlarissa A Sinnappah, Sophie L Stocker, Jian Sheng Chan, et al.
Clinical Pharmacokinetics|April 15, 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation ProteinsQing Xi Ooi, Daniel F B Wright, R Campbell Tait, et al.
The New Zealand Medical Journal|August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is neededStephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
British Journal of Clinical Pharmacology|March 6, 2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin timePaul K L Chin, Daniel F B Wright, David M Patterson, et al.
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
Pageof 8